President Trump signed an executive order on Monday aimed at increasing federal research focus on women's health issues. The order formally establishes a new Women’s Health Division within the National Institutes of Health (NIH) and creates a corresponding White House Women’s Health Task Force to coordinate these efforts across the federal government.

During the signing, the President credited First Lady Melania Trump for her advocacy and role in bringing the issue to the forefront of the administration's agenda. The task force is slated to be led by the White House chief of staff, signaling a high level of administrative oversight for the new division's research goals. While the administration frames this as a significant step toward addressing gaps in medical research for women, the move is part of a broader, ongoing debate regarding the scope and funding of federal health initiatives.

The establishment of this division marks a structural change in how the NIH organizes its research portfolio, moving toward a more centralized approach for women’s health. Proponents suggest this will lead to more targeted funding and better health outcomes, while critics often raise questions about whether such administrative shifts are accompanied by sufficient budgetary increases to make a tangible difference in clinical care. As of now, the administration has focused on the creation of the task force as the primary mechanism for driving these new health research priorities.